A law firm partner has avoided personal liability for costs after expert reports were filed late in a dispute with developer Mirvac over alleged defects in a Sydney apartment complex, having walked back an appeal to “competing commitments” that didn’t wash in court.
Plaintiff firm Maurice Blackburn will foot the bill for the unsuccessful class action against Monsanto over weed killer Roundup, but the company’s reluctance to split the trial in two has come back to bite it.
The previous head of First Nations strategy of the Collingwood Football Club has brought Fair Work proceedings against their former employer, claiming they were unfairly terminated after making several complaints against CEO Craig Kelly about alleged racially insensitive comments.
A former EY partner and ousted board member at National Tiles has lost his $1 million claim alleging the company breached implied terms in a contract by requiring him to sign a “draconian, unreasonable and unacceptable” share agreement.
A judge overseeing a dispute over an employer’s confidential information has urged litigants to remember their legal costs at an early stage of settlement negotiations, rather than leaving it to the court as the “default option”.
Booktopia’s administrators have been given more time to try to sell the online bookseller after receiving 100 expressions of interest, with a judge finding it could yield greater returns for its 170,000 creditors, who are owed a total of $68 million.
A law firm is investigating claims against the manufacturers of popular heartburn and acid reflux drugs, alleging they could be responsible for causing stomach cancers and kidney failure in approximately 100,000 people.
Dutch paint company AkzoNobel has lost a mid-trial bid to inspect instructions given by Allen & Overy to experts who tested its allegedly unsuitable protective coating used on pipework on the $45 billion Ichthys natural gas project.
In the first-ever settlement approval hearing involving a group costs order, a contradictor has argued that Slater & Gordon should have provided the court with more information on legal costs and internal rate of return as part of its bid for a $12.8 million contingency fee.
A judge has dismissed a class action alleging Monsanto’s Roundup weed killer is carcinogenic but did not go so far as to say it definitively does not cause cancer, while also dressing down the lawyers for both sides for causing delays in the case.